Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Trial details
- Registry ID
- NCT07001800
- Phase
- Phase 2, Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyNCT07001800 | KARD | Phase 2, Phase 3 | Recruiting | 2028-08-31Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |